Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network

计划入组 14,607 人 · 首次发布于 2021 年 6 月 24 日

PMT for MDRO Decolonization

计划入组 32 人 · 首次发布于 2022 年 11 月 30 日

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria

计划入组 60 人 · 首次发布于 2026 年 4 月 13 日

MD13

MD23

MR3

MDRC

United States

Maralixibat Demonstrates Efficacy in Treating Pruritus and Reducing Bile Acids in PFIC Patients

ReShape Lifesciences Achieves Early EU MDR Certification for Obesity Treatment Devices

Shattuck Labs Announces Key Milestones for SL-325 Program Targeting Inflammatory Diseases